Ledger.Open graph →
SEC Form D · filed November 16, 2023

VYNE Therapeutics Inc

Offering
$88.2M
Sold
$88.2M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
BRIDGEWATER, NJ
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (18)

Steven Basta · BRIDGEWATER, NJDirectorSharon Barbari · BRIDGEWATER, NJDirectorMutya Harsch · BRIDGEWATER, NJExecTyler Zeronda · BRIDGEWATER, NJExecDavid Domzalski · BRIDGEWATER, NJExec · DirectorElisabeth Sandoval · BRIDGEWATER, NJDirectorPatrick Lepore · BRIDGEWATER, NJDirectorIain Stuart · BRIDGEWATER, NJExecAnthony Bruno · Pompano Beach, FLDirectorSharon Barbari · BRIDGEWATER, NJDirectorMutya Harsch · BRIDGEWATER, NJExecTyler Zeronda · BRIDGEWATER, NJExecDavid Domzalski · BRIDGEWATER, NJExec · DirectorElisabeth Sandoval · BRIDGEWATER, NJDirectorPatrick Lepore · BRIDGEWATER, NJDirectorSteven Basta · Palo Alto, CADirectorIain Stuart · BRIDGEWATER, NJExecAnthony Bruno · Austin, TXDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗